These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 3224029

  • 1. [Changes in tissue T1 of brain tumor following GD-DTPA administration--differences in T1 time course and tissue-blood ratio by histological types].
    Yoshida K, Furuse M, Kaneoke Y, Sasou K, Motegi Y.
    No To Shinkei; 1988 Jun; 40(6):531-7. PubMed ID: 3224029
    [Abstract] [Full Text] [Related]

  • 2. Assessment of T1 time course changes and tissue-blood ratios after Gd-DTPA administration in brain tumors.
    Yoshida K, Furuse M, Kaneoke Y, Saso K, Inao S, Motegi Y, Ichihara K, Izawa A.
    Magn Reson Imaging; 1989 Jun; 7(1):9-15. PubMed ID: 2918823
    [Abstract] [Full Text] [Related]

  • 3. [Brain and spinal tumors: magnetic resonance imaging using gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)].
    Fang YX.
    Zhonghua Yi Xue Za Zhi; 1989 Jun; 69(6):305-7, 22. PubMed ID: 2804747
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Role of Gadolinium-DTPA in the assessment of renal tumors with magnetic resonance].
    Torricelli P, Montanari N, De Santis M, Pollastri C.
    Radiol Med; 1994 May; 87(5):653-61. PubMed ID: 8008898
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The contrast enhancement of brain and spinal cord tumors using Gd-DTPA in magnetic resonance tomography with an extra-low magnetic-field intensity].
    Kornienko VN, Pronin IN, Turkin AM, Fadeeva LM.
    Zh Vopr Neirokhir Im N N Burdenko; 1993 May; (4):13-7. PubMed ID: 8296501
    [Abstract] [Full Text] [Related]

  • 9. Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues.
    Hoehn-Berlage M, Bockhorst K.
    Technol Health Care; 1994 Dec; 2(4):247-54. PubMed ID: 7842309
    [Abstract] [Full Text] [Related]

  • 10. [Gadolinium-DTPA in magnetic resonance tomography. Clinical use--indications].
    Prayer L, Imhof H, Stiglbauer R, Kramer J, Wimberger D.
    Rontgenblatter; 1989 Dec; 42(12):493-8. PubMed ID: 2609069
    [Abstract] [Full Text] [Related]

  • 11. [Blood volume changes after the radiotherapy of the central nervous system].
    Wenz F, Fuss M, Scholdei R, Essig M, Lohr F, Rempp K, Brix G, Knopp MV, Engenhart R, Wannenmacher M.
    Strahlenther Onkol; 1996 Oct; 172(10):559-66. PubMed ID: 8966673
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gadolinium-DTPA enhancement of soft tissue tumors in magnetic resonance imaging.
    Herrlin K, Ling LB, Pettersson H, Willén H, Rydholm A.
    Acta Radiol; 1990 May; 31(3):233-6. PubMed ID: 2386637
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Application of Gd-DTPA in diseases of the central nervous system.
    Shen TZ, Mei H, Huang XL, Chen XR.
    Chin Med J (Engl); 1991 Apr; 104(4):313-20. PubMed ID: 2065550
    [Abstract] [Full Text] [Related]

  • 17. Gd-DTPA-enhanced MR imaging in pediatric patients after brain tumor resection.
    Bird CR, Drayer BP, Medina M, Rekate HL, Flom RA, Hodak JA.
    Radiology; 1988 Oct; 169(1):123-6. PubMed ID: 3420247
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.